Apparatus for delivering and anchoring implantable medical devices

Information

  • Patent Grant
  • 10582923
  • Patent Number
    10,582,923
  • Date Filed
    Friday, January 30, 2015
    9 years ago
  • Date Issued
    Tuesday, March 10, 2020
    4 years ago
Abstract
An apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis. The distal end portion of the elongate member defines a notch having a face defining an axis. The axis of the face and the longitudinal axis define an acute angle with respect to a first direction along the longitudinal axis. The notch is configured to retain a loop of a suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis. The notch is configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction. The suture has at least one tissue anchor configured to be disposed within the tissue of the patient.
Description
BACKGROUND

This invention relates to a medical device and more particularly to methods and devices for delivering a suture including tissue anchors.


Sutures including tissue anchors have application to a wide variety of surgical procedures including those that require high anchoring strength. For example, one such procedure is directed to female urinary incontinence and involves insertion of a suture to be fixed to bodily tissue under and/or lateral to the urethra to reconstitute the ligamentary support for the urethra. Generally, the suture is inserted into two or more body tissues to couple the body tissues tightly together without knotting the suture.


In other procedures a suture having tissue anchors is coupled to an implant that is configured to support a portion of a body of a patient. In such a procedure, the tissue anchor must be able to support the implant without tearing through the tissue within which it is disposed.


Tissue anchors that are large or have many barbs are often difficult to insert into a tissue. When inserting such tissue anchors, a large incision is often necessary and bulky delivery tools are often used. Using a large incision or bulky delivery tools causes unwanted trauma to the tissue and can weaken the tissue within which the tissue anchor is disposed. Thus, a need exists for devices and methods that can be used to effectively deliver a suture having tissue anchors to a tissue of a patient.


SUMMARY

An apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis. The distal end portion of the elongate member defines a notch having a face defining an axis. The axis of the face and the longitudinal axis define an acute angle with respect to a first direction along the longitudinal axis. The notch is configured to retain a loop of a suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis. The notch is configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction. The suture has at least one tissue anchor configured to be disposed within the tissue of the patient.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of a suture attached to a delivery device, according to an embodiment.



FIGS. 2 and 3 are schematic illustrations of the delivery device of FIG. 1 inserting the suture of FIG. 1 into a tissue of a patient.



FIG. 4 is a schematic illustration of a suture attached to a delivery device, according to an embodiment.



FIG. 5 is a perspective view of a delivery device, according to an embodiment.



FIG. 6 is a side view of multiple tissue anchors coupled to a suture, according to an embodiment.



FIG. 7 is a side view of a tissue anchor shown in FIG. 6.



FIG. 8 is a perspective view of the suture of FIG. 6 attached to the delivery device of FIG. 5.



FIG. 9 is a perspective view of an adjustable stop, according to an embodiment.



FIGS. 10 and 11 are front views of the adjustable stop of FIG. 9 in a first configuration and a second configuration, respectively.



FIG. 12 is a perspective view of the adjustable stop of FIG. 9 and the suture of FIG. 6 coupled to the delivery device of FIG. 5.



FIG. 13 is a flow chart illustrating a method of placing a suture within a body of a patient according to an embodiment.





DETAILED DESCRIPTION

In some embodiments, an apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis. The distal end portion of the elongate member defines a notch having a face defining an axis. The axis of the face and the longitudinal axis define an acute angle with respect to a first direction along the longitudinal axis. The notch is configured to retain a loop of a suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis. The notch is configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction. The suture has at least one tissue anchor configured to be disposed within the tissue of the patient.


In some embodiments, an apparatus includes an elongate member and an adjustable stop. The elongate member has a distal end portion and a proximal end portion. The distal end portion of the elongate member defines a notch configured to releasably retain a loop of a suture when the elongate member is inserted into a tissue of a patient a distance. The adjustable stop is movably coupled to the elongate member. The adjustable stop is configured to allow a user to determine the distance the elongate member is inserted into the tissue.


In some embodiments, an apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis and an outer perimeter. The distal end portion of the elongate member has a tissue piercing tip and an oblique shoulder facing toward the tissue piercing tip. The oblique shoulder is disposed proximal to the tissue piercing tip along the longitudinal axis and is within the outer perimeter defined by the elongate member.


In some embodiments, a medical device includes an elongate member, a suture and an anchor. The elongate member has a distal end portion and a proximal end portion. The distal end portion of the elongate member defines a notch. The suture has a distal end portion and a proximal end portion. The distal end portion of the suture has a loop configured to be inserted into the notch. The notch is configured to retain the loop of the suture when the elongate member is inserted into a tissue of a patient. The anchor is coupled to the suture and configured to retain the suture within the tissue of the patient when the suture is disposed within the tissue of the patient and the elongate member is removed from the tissue of the patient.


In some embodiments, a method of inserting a suture within a body of a patient includes sliding an adjustable stop along an elongate member. A loop of a suture is attached to a distal end portion of the elongate member. A tissue anchor is coupled to the suture. The tissue anchor is inserted into a tissue of a patient by moving the elongate member through the tissue of the patient until the adjustable stop contacts an outer surface of the tissue of the patient. The distal end portion of the elongate member is disposed within the tissue a distance from the outer surface of the tissue. The distance from the outer surface of the tissue is substantially equal to a distance between the distal end portion of the elongate member and the adjustable stop. The loop of the suture is the released from the distal end portion of the elongate member and the elongate member is removed from the body of the patient.


As used herein, the terms proximal portion or proximal end refer to the portion or end, respectively, of a device that is closest to a medical practitioner (e.g., a physician) when performing a medical procedure, and the terms distal portion or distal end refer to the portion or end, respectively, of the device that is furthest from the physician during a medical procedure. For example, the end of a medical device first inserted inside the patient's body would be the distal end of the medical device, while the end of the medical device handled by the medical practitioner would be the proximal end of the medical device.



FIG. 1 is a schematic illustration of a suture 120 attached to a delivery device 110, according to an embodiment. The suture 120 includes a proximal end portion 124, a distal end portion 122 and a tissue anchor 130. The suture 120 can be made of any biocompatible material. For example, the suture 120 can be a monofilament suture, a braided suture, a tape, a mesh, include a mesh-like material and/or any other material known in the art. In some embodiments, the suture is similar to the sutures shown and described in U.S. Provisional Patent Application No. 61/071,726 entitled “Surgical Composite Barbed Suture,” filed on May 14, 2008, which is hereby incorporated by reference in its entirety.


The proximal end portion 124 of the suture 120 is configured to be attached to any device configured to be retained within a body of a patient, such as an implant (not shown in FIG. 1). Such an implant can be configured to be placed within a body of a patient and can be configured to support a portion of the body. For example, the implant can be similar to the implants or grafts disclosed in U.S. Patent Application No. 61/017,257 entitled “Apparatus and Method for Uterine Preservation,” filed on Dec. 28, 2007, which is hereby incorporated by reference in its entirety. The implant can be a variety of different shapes, sizes and configurations depending on the intended use for the particular implant. In some embodiments, the implant can be substantially rectangular, square, oval, or elliptical. The implant can be shaped and sized to support a bladder and/or a bladder neck (e.g., to treat a cystocele), a uterus (e.g., to treat a hysterocele) and/or a rectum (e.g. to treat a rectocele).


The implant can be formed with a mesh material to allow tissue in-growth to the implant after implantation. For example, some or all of the implant can be formed with a mesh material as described in U.S. Patent Pub. 2005/0038452 A1 to Chu, the disclosure of which is hereby incorporated by reference in its entirety. In some embodiments, some or all of the implant can be formed with the Advantage® Mesh or the Polyform™ Synthetic Mesh material each provided by Boston Scientific Corporation.


The distal end portion 122 of the suture 120 includes an attachment portion 123 configured to be releasably attached to the delivery device 110, described in further detail herein. In some embodiments, the attachment portion 123 of the distal end portion 122 of the suture 120 can be, for example, a loop configured to be inserted into a notch 115 of the delivery device 110. In other embodiments, the attachment portion can be a clip, an adhesive portion, and/or any other attachment mechanism known in the art.


The tissue anchor 130 can be any device configured to retain the suture 120 within a tissue of a patient. In some embodiments, for example, the tissue anchor 130 is similar to the tissue anchors shown and described in U.S. Provisional Patent Application No. 61/071,726 entitled “Surgical Composite Barbed Suture,” filed on May 14, 2008, which is hereby incorporated by reference in its entirety.


The tissue anchor 130 is configured to retain its position with respect to bodily tissue when inserted into bodily tissue. In some embodiments, the tissue anchor 130 includes a retaining member, for example, a barb, a prong, a tab, and/or any other retaining member known in the art. In other embodiments, the tissue anchor includes multiple retaining members extending from the elongate member. In some embodiments, the retaining members can flex or bend to facilitate insertion into bodily tissue. In other embodiments, the retaining members are rigid and are not configured to bend or flex during insertion.


The tissue anchor 130 is constructed of any suitable material. In some embodiments, for example, the tissue anchor 130 is constructed of a biocompatible polymer, a metal, and/or any other material known in the art. In some embodiments, the tissue anchor 130 includes an opaque material to increase the visibility of the medical practitioner during insertion of the suture 120.


The tissue anchor 130 is coupled to the suture 120 by any suitable means. In some embodiments, for example, the tissue anchor 130 is coupled to the suture 120 via a knot, an adhesive, such as, for example, glue, and/or any other attachment mechanism known in the art. In other embodiments, the tissue anchor is monolithically formed with the suture and/or molded to the suture. In some embodiments, the tissue anchor 130 is coupled near the distal end portion 122 of the suture 120. In such embodiments, the distal end portion 112 of the delivery device 110 need not be inserted as far into the body of the patient for the tissue anchor 130 to be disposed within the tissue of the patient. This decreases the trauma caused to the tissue of the patient beyond the portion of the tissue where the tissue anchor 130 is disposed.


The delivery device 110 includes a distal end portion 112 and a proximal end portion 114 and defines a longitudinal axis AL. The delivery device 110 is configured to be moved through a tissue of a patient in a direction substantially parallel to the longitudinal axis AL. In some embodiments, the delivery device 110 is substantially rigid and/or solid. In other embodiments, the delivery device defines a lumen. The proximal end portion 114 of the delivery device 110 is controlled by the medical practitioner directly by holding the proximal end portion 114 or indirectly by controlling another device coupled to the proximal end portion 114 when the distal end portion 112 of the delivery device 110 is inserted into the tissue of the patient.


The distal end portion 112 of the delivery device 110 defines a notch 115 or a shoulder configured to releasably retain the attachment portion 123 of the distal end portion 122 of the suture 120. The notch 115 includes a first face 117 and a second face 116. The first face 117 defines an axis AF1. In other embodiments, the notch only includes a first face. In some embodiments, the notch 115 or shoulder is within an outer parameter defined by the delivery device 110. In other embodiments, the notch or shoulder extends outside the outer parameter defined by the delivery device.


The axis AF1 of the first face 117 defines an angle SF1 with the longitudinal axis AL. The angle SF1 defined by the axis AF1 of the first face 117 and the longitudinal axis AL is acute with respect to a first direction shown by the arrow AA in FIGS. 1 and 2. The angle SF1 is configured to retain the attachment portion 123 of the suture 120 when the delivery device 110 is moved in the first direction AA, as described in further detail herein.


Similarly, the second face 116 defines an axis AF2. The axis AF2 of the second face 116 defines an angle 0F2 with the longitudinal axis AL. The angle 0F2 defined by the axis AF2 of the second face 116 and the longitudinal axis AL is obtuse with respect to a second direction shown by the arrow BB in FIGS. 1 and 3. The angle 0F2 is configured to allow the attachment portion 123 of the suture 120 to become uncoupled from the notch 115 of the delivery device 110 when the delivery device 110 is moved in the second direction BB, as described in further detail herein.


The distal end portion 112 of the delivery device 110 is configured to be inserted into the body of the patient to assist in delivering the suture 120 within a tissue of the patient. In some embodiments, the distal end portion includes a tapered portion configured to pierce and/or dilate tissue as the delivery device is inserted into the tissue of the patient.


In use, the suture 120 is attached to the delivery device 110 by attaching the attachment portion 123 of the distal end portion 122 of the suture 120 to the notch 115 defined by the delivery device 110. In some embodiments, this includes inserting a loop of the suture 120 into the notch 115 of the delivery device 110. The proximal end portion 124 of the suture 120 is aligned substantially parallel to the longitudinal axis AL defined by the delivery device 110. Said another way, a longitudinal axis defined by the suture is aligned such that it is substantially parallel to the longitudinal axis AL defined by the delivery device 110. Positioning the suture 120 along the longitudinal axis AL allows the suture 120 to be inserted into the tissue of the patient through a lumen created by the delivery device 110 as the delivery device 110 moves through the tissue of the patient.



FIGS. 2 and 3 are schematic illustrations of the delivery device 110 inserting the suture 120 into a tissue of a patient. The delivery device 110 and the suture 120 are inserted into the tissue of the patient by moving the delivery device 110 with respect to the tissue in a first direction along the longitudinal axis AL shown by the arrow AA in FIG. 2. The first face 117 of the notch 115 exerts a force on the attachment portion 123 of the suture 120 that is normal to the first face 117 of the notch 115 as the delivery device 110 is moved in the first direction AA. Because the angle SF1 defined by the axis AF1 of the first face 117 of the notch 115 is acute with respect to the first direction AA, the force exerted on the attachment portion 123 of the suture 120 by the first face 117 of the notch 115 retains the attachment portion 123 of the suture 120 in the notch 115 as the delivery device 110 is moved in the first direction AA.


Once the tissue anchor 130 reaches a depth within the tissue where it is to be disposed, the medical practitioner can release the attachment portion 123 of the suture 120 from the notch 115 of the delivery device 110 by moving the delivery device 110 in a second direction along the longitudinal axis AL shown by the arrow BB in FIG. 3. The second direction BB is substantially opposite the first direction AA. Because the angle SF2 defined by the axis AF2 of the second face 116 of the notch 115 and the longitudinal axis AL is obtuse with respect to the second direction BB, the attachment portion 123 of the suture 120 is released from the notch 115 as the delivery device 110 is moved in the second direction BB.


Said another way, when the delivery device 110 is moved in the second direction BB, the second face 116 of the notch 115 exerts a force on the attachment portion 123 of the suture 120 that is normal to the second face 116. This force pushes the attachment portion 123 of the suture 120 out of the notch 115. Once the attachment portion 123 of the suture 120 is released from the notch 115, the medical practitioner can remove the delivery device 110 from the tissue of the patient by continuing to move the delivery device 110 in the second direction BB.



FIG. 4 is a schematic illustration of a suture 220 attached to a delivery device 210, according to another embodiment. The suture 220 includes a proximal end portion 224, and a distal end portion 222. The proximal end portion 224 of the suture 220 is configured to be attached to any device configured to be retained within a body of a patient, such as an implant (not shown in FIG. 4).


The distal end portion 222 of the suture 220 includes an attachment portion 223 configured to be releasably attached to the delivery device 210. In some embodiments, the attachment portion 223 of the distal end portion 222 of the suture 220 can be, for example, a loop configured to be inserted into a notch 215 of the delivery device 210. In other embodiments, the attachment portion 223 can be a clip, an adhesive portion, and/or any other attachment mechanism known in the art.


In some embodiments, the suture 220 includes a tissue anchor (not shown in FIG. 4) and/or another device configured to assist in retaining the suture within the tissue of the patient. In other embodiments, the suture does not include a tissue anchor. In such embodiments, the friction between the tissue surrounding the suture and the suture can help retain the suture within the tissue.


The delivery device 210 includes a distal end portion 212 and a proximal end portion 214 and defines a longitudinal axis AL. The delivery device 210 is configured to be moved through a tissue of a patient in a direction substantially parallel to the longitudinal axis AL. In some embodiments, the delivery device 210 is substantially rigid and/or solid. In other embodiments, the delivery device defines a lumen. The proximal end portion 214 of the delivery device 210 is controlled by the medical practitioner directly by holding the proximal end portion 214 or indirectly by controlling another device coupled to the proximal end portion 214 when the distal end portion 212 of the delivery device 210 is inserted into the tissue of the patient.


The distal end portion 212 of the delivery device 210 defines a notch 215 or a shoulder configured to releasably retain the attachment portion 223 of the distal end portion 222 of the suture 220. The distal end portion 212 of the delivery device 210 is configured to be inserted into the body of the patient to assist in delivering the suture 220 within a tissue of the patient. In some embodiments, the distal end portion includes a tapered portion configured to pierce and/or dilate tissue as the delivery device is inserted into the tissue of the patient.


An adjustable stop 218 is movably coupled to the delivery device 210. The adjustable stop 218 is configured to be disposed in at least two positions with respect to the delivery device 210. In some embodiments, for example, the adjustable stop 218 has a first configuration and a second configuration. When the adjustable stop 218 is in its first configuration, the location of the adjustable stop 218 with respect to the delivery device 210 is fixed. Said another way, when the adjustable stop 218 is in its first configuration it cannot slide with respect to the delivery device 210. Accordingly, when the adjustable stop 218 is in its first configuration, the distance D shown in FIG. 4 does not change and the adjustable stop's 218 position with respect to the delivery device 210 is fixed. When the adjustable stop 218 is in its second configuration it is configured to slide with respect to the delivery device 210 in a direction substantially along the longitudinal axis AL.


In other embodiments, the adjustable stop does not slide with respect to the delivery device but instead is coupled to the delivery device in a desired location with respect to the delivery device. In such embodiments, in order to move the adjustable stop with respect to the delivery device the adjustable stop is uncoupled from the delivery device and recoupled to the delivery device in another location.


The adjustable stop 218 is configured to help limit the distance that the distal end portion 212 of the delivery device 210 can be inserted into the tissue of the patient. The distance that the distal end portion 212 of the delivery device 210 can be inserted into the patient is substantially equal to the distance between the distal end portion 212 of the delivery device 210 and the adjustable stop 218 shown as distance D in FIG. 4. Having an adjustable stop 218 prevents a medical practitioner from inserting the distal end portion 212 of the delivery device 210 into the tissue of the patient further than expected, causing unwanted harm to the patient. The adjustable stop 218 also provides the medical practitioner with the ability to determine a depth within the tissue of the patient where the distal end portion 224 of the suture 220 is to be disposed, and, using the adjustable stop 218, set the delivery device 210 to deliver the distal end portion 224 of the suture 220 to this depth, as further described in detail herein.


In use, the medical practitioner moves the adjustable stop 218, in its second configuration, with respect to the delivery device 210 to adjust the distance D between the distal end portion 212 of the delivery device 210 and the adjustable stop 218. As discussed above, the distance D corresponds to the depth the distal end portion 212 of the delivery device can be inserted into the tissue of the patient. Once the adjustable stop 218 is in the position along the delivery device 210 that corresponds to the desired depth, the adjustable stop 218 is moved from its second configuration to its first configuration. As discussed above, when the adjustable stop 218 is in its first configuration, the location of the adjustable stop 218 with respect to the delivery device 210 is fixed. Accordingly, the desired depth cannot be inadvertently changed prior to and/or during the insertion process.


The suture 220 is attached to the delivery device 210 by attaching the attachment portion 223 of the distal end portion 222 of the suture 220 to the notch 215 defined by the delivery device 210. In some embodiments, this includes inserting a loop of the suture 220 into the notch 215 of the delivery device 210. The proximal end portion 224 of the suture 220 is aligned substantially parallel to the longitudinal axis AL defined by the delivery device 210. Once the adjustable stop 218 has been adjusted and moved to its first configuration and the suture 220 has been attached to the delivery device 210, the suture 220 can be inserted into the tissue of the patient similar to suture 120.



FIG. 5 is a perspective view of a delivery device 310 configured to deliver a suture within a tissue of a patient, according to another embodiment. The delivery device 310 includes a distal end portion 312 and a proximal end portion 314 and defines a longitudinal axis AL. The delivery device 310 is configured to be moved through the tissue of the patient in a direction substantially parallel to the longitudinal axis AL. In some embodiments, the delivery device 310 is substantially rigid and/or solid. In other embodiments, the delivery device defines a lumen. The proximal end portion 314 of the delivery device 310 is controlled by the medical practitioner directly by holding the proximal end portion 314 or indirectly by controlling another device coupled to the proximal end portion 314 when the distal end portion 312 of the delivery device 310 is inserted into the tissue of the patient.


The proximal end portion 314 of the delivery device 310 is configured to be held by a medical practitioner and/or indirectly controlled by a medical practitioner when the distal end portion 312 of the delivery device is inserted into the tissue of the patient.


The distal end portion 312 of the delivery device 310 includes a tapered portion 313 and defines a notch 315 or a shoulder. The distal end portion 312 of the delivery device 310 is configured to be inserted into the tissue of the patient to assist in delivering a suture within the tissue of the patient. The tapered portion 313 of the distal end portion 312 has a sharp tip configured to pierce the tissue and is tapered. This allows the tapered portion 313 to dilate tissue as the delivery device 310 is inserted into the tissue of the patient. Accordingly, the tapered portion 313 pierces and dilates a tissue in which a suture will be disposed.


The notch 315 defined by the distal end portion 312 of the delivery device 310 is configured to releasably retain an attachment portion of a suture. The attachment portion of the suture can be, for example, a loop on the distal end portion of the suture and/or any other attachment mechanism known in the art. The notch 315 includes a first face 317 and a second face 316. In other embodiments, the notch includes only a first face. In some embodiments, the notch 315 or shoulder is within an outer parameter defined by the delivery device 310. In other embodiments, the notch or shoulder extends outside the outer parameter defined by the delivery device.


The first face 317 defines an axis AF1. The axis AF1 of the first face 317 defines an angle 8F1 with the longitudinal axis AL. The angle 8F1 defined by the axis AF1 of the first face 317 and the longitudinal axis AL is acute with respect to a first direction shown by the arrow CC in FIG. 5. The angle 8F1 is configured to retain the attachment portion of the suture 320 when the delivery device 310 is moved in the first direction CC, as described in further detail herein.


Similarly, the second face 316 defines an axis AF2. The axis AF2 of the second face 316 defines an angle OF2 with the longitudinal axis AL. The angle OF2 defined by the axis AF2 of the second face 316 and the longitudinal axis AL is obtuse with respect to a second direction shown by the arrow DD in FIG. 5. The angle OF2 is configured to allow the attachment portion of the suture to become uncoupled from the notch 315 of the delivery device 310 when the delivery device 310 is moved in the second direction DD, as described in further detail herein.



FIGS. 6 and 7 show a side view of multiple tissue anchors 420 coupled to a suture 410 and a perspective view of a tissue anchor 420, respectively, according to another embodiment. The suture 410 includes a distal end portion 414 and a proximal end portion 416. The suture 410 can be made of any biocompatible material. For example, the suture 410 can be a monofilament suture, a braided suture, a tape, a mesh, include a mesh-like material and/or any other material known in the art.


The distal end portion 414 of the suture 410 includes a loop 412. The loop 410 is configured to be releasably coupled to a delivery device, as described in further detail herein. In some embodiments, for example, the loop 412 is configured to be releasably coupled to a notch of a delivery device such as the notch 315 of delivery device 310. In other embodiments, the suture can include other attachment mechanisms, such as, for example, a clip, an adhesive portion, and/or any other attachment mechanism known in the art.


The tissue anchor 420 has a first end portion 421 and a second end portion 423 opposite the first end portion 421. As shown in FIG. 6, the first end portion 421 of the tissue anchor 420 includes a coupling portion 428 coupled to the suture 410. The second end portion 423 of the tissue anchor 420 includes a coupling portion 430 coupled to the suture 410. Specifically, the tissue anchor 420 has a first side portion 445 and a second side portion (not shown) opposite the first side portion 445. The tissue anchor 420 defines a first opening 441 that extends from the first side portion 445 to the second side portion. The coupling portion 428 of the first end portion 421 includes the inner wall 443 of the first opening 441 such that when the suture 410 is coupled to the first end portion 421, the suture 410 engages the inner wall 443 of the first opening 441 of the first end portion 421 as shown in FIG. 6. Similarly, the tissue anchor 420 defines a second opening 442 that extends from the first side portion 445 to the second side portion. The coupling portion 430 of the second end portion 423 includes an inner wall 444 of the second opening 442 of the second end portion 423 such that when the suture 410 is coupled to the second end portion 423 the suture 410 engages the inner wall 444 of the second opening 442 of the second end portion 423 as shown in FIG. 6.


As shown in FIG. 6, the suture 410 is coupled to the first end portion 421 and the second end portion 423. Specifically, a portion of the inner wall 443 of the first opening 441 is disposed within a first knot formed by the suture 410. Similarly, a portion of the inner wall 444 of the second opening 442 is disposed within a second knot formed by the suture 410. In some embodiments, the suture 410 can form more or less than two knots. In other embodiments, the tissue anchor can be coupled to the suture in any suitable manner. For example, the tissue anchor can be coupled to the suture via the methods shown and described in U.S. Provisional Patent Application No. 61/071,726 entitled “Surgical Composite Barbed Suture,” filed on May 14, 2008, which is hereby incorporated by reference in its entirety.


The tissue anchor 420 includes multiple retaining members 434, 435, 436, 437. The retaining members 434, 435, 436, 437 are configured to allow movement of the suture 410 with respect to the tissue through the tissue of the patient in a first direction shown by the arrow EE in FIG. 6. This allows the suture 410 to pass through the tissue of the patient when being inserted into the tissue of the patient, as further described herein. The retaining members 434, 435, 436, 437 help limit the movement of the suture 410 with respect to the tissue in a second direction, substantially opposite the first direction shown by the arrow FF in FIG. 6. Accordingly, once the suture 410 is placed within the tissue of the patient the anchors 420 help prevent the suture 410 from inadvertently becoming dislodged from the tissue.



FIG. 8 is a side perspective view of the suture 410 shown in FIG. 6 attached to the delivery device 310 shown in FIG. 5. The suture 410 is attached to the delivery device 310 by attaching the loop 412 of the suture 410 to the notch 315 defined by the delivery device 310. The proximal end portion 416 of the suture 410 is aligned substantially parallel to the longitudinal axis AL defined by the delivery device 310. Said another way, a longitudinal axis defined by the suture is aligned such that it is substantially parallel to the longitudinal axis AL defined by the delivery device 310. Positioning the suture 410 along the longitudinal axis AL allows the suture 410 to be inserted into the tissue of the patient through a lumen created by the delivery device 310 as the delivery device 310 moves through the tissue of the patient.


The delivery device 310 and the suture 410 are inserted into the tissue of the patient by moving the delivery device 310 with respect to the tissue in a first direction along the longitudinal axis AL shown by the arrow GG in FIG. 8. The first face 317 of the notch 315 exerts a force on the loop 412 of the suture 410 that is normal to the first face 317 of the notch 315 as the delivery device 310 is moved in the first direction GG. Because the angle 0F1 defined by the axis AF1 of the first face 317 of the notch 315 and the longitudinal axis AL is acute with respect to the first direction GG, the force exerted on the loop 412 of the suture 410 by the first face 317 of the notch 315 retains the loop 412 of the suture 410 in the notch 315 as the delivery device 310 is moved in the first direction GG.


Once the tissue anchor 420 reaches a depth within the tissue where it is to be disposed, the medical practitioner can release the loop 412 of the suture 410 from the notch 315 of the delivery device 310 by moving the delivery device 310 in a second direction along the longitudinal axis AL shown by the arrow HH in FIG. 8. The second direction HH is substantially opposite the first direction GG. Because the angle eF2 defined by the axis AF2 of the second face 316 of the notch 315 and the longitudinal axis AL is obtuse with respect to the second direction HH, the loop 412 of the suture 410 is released from the notch 315 as the delivery device 310 is moved in the second direction HH. Said another way, when the delivery device 310 is moved in the second direction HH, the second face 316 of the notch 315 exerts a force on the loop 412 of the suture 410 that is normal to the second face 316. This force pushes the loop 412 of the suture 410 out of the notch 315. Once the loop 412 of the suture 410 is released from the notch 315, the medical practitioner can remove the delivery device 310 from the tissue of the patient by continuing to move the delivery device 310 in the second direction HH.



FIG. 9 is a side perspective view of an adjustable stop 500, according to another embodiment. The adjustable stop 500 is configured to limit the depth the delivery device can be inserted into a tissue of a patient. The adjustable stop 500 includes a body portion 510, a first leg portion 530 and a second leg portion 540. The body portion 510 includes a first face 512 and a second face (not shown). The first face 512 of the body portion 510 are shown in FIG. 9 as being substantially circular in shape. In other embodiments, faces of the body portion can be any other suitable shape, such as, for example, triangular, square, and/or hexagonal.


The body portion 510 defines a lumen 514 and a slit 520. The lumen 514 extends the entire length of the body portion 510 of the adjustable stop 500. Said another way, the lumen extends from the first face 512 of the body portion 510 to the second face (not shown) of the body portion 510.


The first leg portion 530 of the adjustable stop 500 and the second leg portion 540 of the adjustable stop 540 extend from the body portion 510 of the adjustable stop 500. The first leg portion 530 and the second leg 540 portion cross each other as shown in FIG. 9.


The adjustable stop 500 has a first configuration and a second configuration, as shown in FIG. 10 and FIG. 11 respectively. When the adjustable stop 500 is in its first configuration (FIG. 10), the lumen 514 has a size that is substantially equal to the size of a delivery device, such as the delivery device 310 shown and described in FIG. 5. Additionally, when the adjustable stop 500 is in its first configuration, the slit 520 has a width that is less than a width of the delivery device. As such, a delivery device not disposed within the lumen 514 is prevented from passing through the slit 520 and into the lumen 514 and a delivery device disposed within the lumen 514 (see e.g., FIG. 12) is prevented from passing through the slit 520 to be removed from the lumen 514. Further, the position of the adjustable stop 500 with respect to a delivery device disposed within the lumen 514 is fixed. Thus, the adjustable stop 500 is unable to move with respect to a delivery device disposed within the lumen 514 when the adjustable stop 500 is in its first configuration.


When the adjustable stop 500 is in its second configuration (FIG. 11) the lumen 514 has a size that is greater than the size of the delivery device. As such, the delivery device can be inserted into the lumen 514 and the adjustable stop 500 can move with respect to the delivery device. For example, the adjustable stop 500 can slide along the delivery device in a direction substantially parallel to a longitudinal axis defined by the delivery device.


The width of the slit 520 in the second configuration is greater than the width of the slit 520 in the first configuration. The width of the slit 520 in the second configuration, however, is smaller than the width of the delivery device. As such, similar to the first configuration, the delivery device cannot pass through the slit 520. This prevents the delivery device from inadvertently being removed from the lumen 514 when the adjustable stop 500 is in its second configuration.


The adjustable stop 500 can be moved from its first configuration (FIG. 10) to its second configuration (FIG. 11) by squeezing the first leg portion 530 and the second leg portion 540 together. Specifically, to move the adjustable stop 500 into its second configuration a force in the direction shown by the arrow JJ is exerted on the first leg portion 530 and a force in the direction shown by the arrow KK is exerted on the second leg portion 540. This causes the lumen 514 and the slit 520 to expand. As discussed above, once in the second configuration, the adjustable stop 500 can be coupled to the delivery device and can be moved with respect to the delivery device.


The adjustable stop 500 is biased in its first configuration. Thus, to return the adjustable stop 500 to its first configuration, the force exerted on the first leg portion 530 and the force exerted on the second leg portion 540 are released. This causes the lumen 514 and the slit 520 to contract back to the first configuration.


The adjustable stop 500 is configured to help limit the distance that a distal end portion of the delivery device can be inserted into the tissue of the patient. The distance that the distal end portion of the delivery device can be inserted into the patient is substantially equal to the distance between the distal end portion of the delivery device and the adjustable stop 500. Having an adjustable stop 500 prevents a medical practitioner from inserting the distal end portion of the delivery device into the tissue of the patient further than expected, causing unwanted harm. The adjustable stop 500 also provides the medical practitioner with the ability to determine a depth within the tissue of the patient where a distal end portion of a suture and/or a tissue anchor of the suture is to be disposed, and, using the adjustable stop 500, setting the delivery device to deliver the distal end portion of the suture 500 and/or the tissue anchor of the suture to this depth, as further described in detail herein.


In use, the adjustable stop 500 is moved into its second configuration and coupled to the delivery device. FIG. 12 shows the adjustable stop 500 coupled to the delivery device 310 of FIG. 5. The adjustable stop 500 can be moved with respect to the delivery device 310 in order to set a depth to which a distal end portion 414 of a suture 410 or a tissue anchor 420 of the suture 410 will be disposed. Once the adjustable stop 500 is in the desired position with respect to the delivery device 310, it is moved from its second configuration to its first configuration. As described above, when the adjustable stop 500 is in its first configuration, the position of the adjustable stop 500 with respect to the delivery device 310 is substantially fixed.


A suture 410 is releasably coupled to the distal end portion 312 of the delivery device 310. This can be accomplished by any of the methods described above. The distal end portion 312 of the delivery device 310 is inserted into the tissue of the patient in a first direction until the second face (not shown) of the adjustable stop contacts the outer surface of the tissue. Once the second face of the adjustable stop contacts the outer surface of the tissue, the distal end portion 312 of the delivery device 310 cannot be inserted deeper into the tissue (i.e., the skin near the insertion site). The suture is released from the distal end portion of the delivery device and the distal end portion of the delivery device removed from the tissue of the patient by moving the delivery device in a second direction, substantially opposite the first direction.



FIG. 13 is a flow chart illustrating a method 600 of placing a suture within a body of a patient, according to another embodiment. The method 600 includes moving an adjustable stop along an elongate member, at 602. The elongate member is a portion of a delivery device. In some embodiments, the delivery device is structurally and functionally similar to the delivery devices shown and described herein. In some embodiments, the adjustable stop is structurally and functionally similar to the adjustable stops shown and described herein.


A loop of a suture is attached to a distal end portion of the elongate member, at 604. A tissue anchor is coupled to the suture. The suture can be attached to the distal end portion of the elongate member by any suitable method. In some embodiments, for example, the suture has a loop configured to attach to a notch defined by the elongate member as shown and described herein. In other embodiments, the suture can be attached to the distal end portion of the elongate member using a clip, an adhesive, glue and/or any other attachment mechanism known in the art.


The tissue anchor is inserted into a tissue of a patient by moving the elongate member through the tissue of the patient until the adjustable stop contacts an outer surface of the tissue of the patient, at 606. The distal end portion of the elongate member is disposed within the tissue a distance from the outer surface of the tissue. The distance is substantially equal to a distance between the distal end portion of the elongate member and the adjustable stop.


The loop of the suture is released from the distal end portion of the elongate member. This can be done by any suitable method. In some embodiments, for example, the elongate member is moved in a direction substantially opposite the direction in which the elongate member was moved to insert the tissue anchor, as shown and described herein. In such embodiments, the movement in the opposite direction causes the loop of the suture to release from the distal end portion of the elongate member. In other embodiments, the loop of the suture can be released from the distal end portion of the elongate member by releasing a clip, waiting for an adhesive to dissolve, moving a switch on a handle, and/or the like.


The elongate member is then removed from the body of the patient. This can be done by moving the elongate member in a direction substantially opposite the direction in which the elongate member was moved to insert the tissue anchor.


While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.


For example, while a single type of adjustable stop is described, any adjustable stop capable of limiting the depth a distal end portion of a delivery device can be inserted into a tissue can be used. For example, the adjustable stop might have a different shape, size, and/or method of moving between its first configuration and its second configuration. In some embodiments, for example, the adjustable stop is moved between its first configuration and its second configuration by use of a switch, a dial, a screw, and/or any other mechanism known in the art.


Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments where appropriate.


An apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis. The distal end portion of the elongate member defines a notch having a face defining an axis. The axis of the face and the longitudinal axis define an acute angle with respect to a first direction along the longitudinal axis. The notch is configured to retain a loop of a suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis. The notch is configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction. The suture has at least one tissue anchor configured to be disposed within the tissue of the patient.


In some embodiments, the loop of the suture remains within the tissue of the patient when the elongate member is moved in the second direction.


In some embodiments, the apparatus further includes an adjustable stop coupled to the elongate member. The adjustable has a first configuration and a second configuration. The adjustable stop is configured to move with respect to the elongate member when in the first configuration and is configured to maintain its position with respect to the elongate member when in the second configuration. The adjustable stop is configured to limit the distance between an outer surface of the tissue and the distal end portion of the elongate member when the adjustable stop is in its second configuration and the elongate member is inserted into the tissue of the patient such that the adjustable stop contacts the outer surface of the tissue.


In some embodiments, the tissue anchor is configured to allow movement of the suture through the tissue of the patient in the first direction and configured to limit movement of the suture through the tissue of the patient in the second direction. In some embodiments, the distal end portion of the elongate member includes a tissue piercing portion configured to penetrate the tissue of the patient.


In some embodiments, the elongate member is substantially solid. In some embodiments, the elongate member is substantially rigid. In some embodiments, the face of the notch is a first face of the notch and the notch has a second face defining an axis. The axis of the second face and the longitudinal axis define an obtuse angle with respect to the second direction.


In some embodiments, a method includes sliding an adjustable stop along an elongate member. A loop of a suture is attached to a distal end portion of the elongate member. A tissue anchor is coupled to the suture. The tissue anchor is inserted into a tissue of a patient by moving the elongate member through the tissue of the patient until the adjustable stop contacts an outer surface of the tissue of the patient. The distal end portion of the elongate member is disposed within the tissue a distance from the outer surface of the tissue. The distance is substantially equal to a distance between the distal end portion of the elongate member and the adjustable stop. The loop of the suture is released from the distal end portion of the elongate member and the elongate member is removed from the body of the patient.


In some embodiments, the inserting includes penetrating the tissue of the patient with the distal end portion of the elongate member. In some embodiments, the inserting includes moving the elongate member through the tissue of the patient in a first direction and the releasing includes moving the elongate member in a second direction substantially opposite the first direction.


In some embodiments, the releasing the loop of the suture from the distal end portion of the elongate member includes moving the elongate member with respect to the tissue of the patient. In some embodiments, the attaching includes inserting the loop of the distal end portion of the suture into a notch defined by the distal end portion of the elongate member.


In some embodiments, the apparatus includes an elongate member having a distal end portion and a proximal end portion and an adjustable stop movably coupled to the elongate member. The distal end portion of the elongate member defines a notch configured to releasably retain a loop of a suture when the elongate member is inserted into a tissue of a patient a distance. The adjustable stop is configured to allow a user to determine the distance the elongate member is inserted into the tissue.


In some embodiments, the adjustable stop defines a face configured to contact an outer portion of the tissue when the elongate member is inserted into the tissue the distance. In some embodiments, the distance is a first distance and the adjustable stop has a first position with respect to the elongate member and a second position with respect to the elongate member. The elongate member is configured to be inserted into the tissue of the patient the first distance when the adjustable stop is in the first position. The elongate member is configured to be inserted into the tissue of the patient a second distance when the adjustable stop is in the second position. The second distance is greater than the first distance.


In some embodiments, the elongate member defines a longitudinal axis and is configured to be inserted into the tissue of the patient in a direction substantially along the longitudinal axis. In some embodiments, the adjustable stop is configured to move with respect to the elongate member. In some embodiments, the notch is configured to retain the loop of the suture when the elongate member is moved in a first direction through the tissue of the patient. The notch is configured to release the loop of the suture when the elongate member is moved in a second direction substantially opposite the first direction.


In some embodiments, the elongate member is substantially solid. In some embodiments, the elongate member is substantially rigid. In some embodiments, at least one tissue anchor configured to be disposed within the tissue of the patient is coupled to the suture.


In some embodiments, an apparatus includes an elongate member having a distal end portion and a proximal end portion. The elongate member defines a longitudinal axis and an outer perimeter. The distal end portion of the elongate member has a tissue piercing tip and an oblique shoulder facing toward the tissue piercing tip. The oblique shoulder is disposed proximal to the tissue piercing tip along the longitudinal axis and is within the outer perimeter defined by the elongate member.


In some embodiments, the oblique shoulder is configured to retain a loop of a suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis. The oblique shoulder is configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction. The suture has at least one tissue anchor configured to be disposed within the tissue of the patient.


In some embodiments, the elongate member is substantially solid. In some embodiments, the elongate member is substantially rigid. In some embodiments the apparatus further includes an adjustable stop coupled to the elongate member. The adjustable stop has a first configuration and a second configuration. The adjustable stop is configured to move with respect to the elongate member when in the first configuration and is configured to maintain its position with respect to the elongate member when in the second configuration. The adjustable stop is configured to limit the distance between an outer surface of the tissue and the distal end portion of the elongate member when the adjustable stop is in its second configuration and the elongate member is inserted into the tissue of the patient such that the adjustable stop contacts the outer surface of the tissue.


In some embodiments, a medical device includes an elongate member having a distal end portion and a proximal end portion, a suture having a distal end portion and a proximal end portion and an anchor coupled to the suture. The distal end portion of the elongate member defines a notch. The distal end portion of the suture has a loop configured to be inserted into the notch. The notch is configured to retain the loop of the suture when the elongate member is inserted into a tissue of a patient. The anchor is configured to retain the suture within the tissue of the patient when the suture is disposed within the tissue of the patient and the elongate member is removed from the tissue of the patient.


In some embodiments, the anchor is configured to allow movement of the suture through the tissue of the patient in a first direction and is configured to help prevent movement of the suture through the tissue of the patient in a second direction substantially opposite the first direction.


In some embodiments, the medical device further includes an adjustable stop coupled to the elongate member. The adjustable stop has a first configuration and a second configuration. The adjustable stop is configured to move with respect to the elongate member when in the first configuration. The adjustable stop is configured to maintain its position with respect to the elongate member when in the second configuration. The adjustable stop configured to limit the distance between an outer surface of the tissue and the distal end portion of the elongate member when the adjustable stop is in its second configuration and the elongate member is inserted into the tissue of the patient such that the adjustable stop contacts the outer surface of the tissue.


In some embodiments, the notch of the distal end portion of the elongate member has a face defining an axis. The axis and a longitudinal axis defined by the elongate member define an acute angle with respect to a distal direction.


In some embodiments, the distal end portion of the elongate member includes a tissue piercing portion configured to penetrate the tissue of the patient. In some embodiments, the elongate member is substantially solid. In some embodiments, the elongate member is substantially rigid.

Claims
  • 1. An apparatus, comprising: a suture;an elongate member having a distal end portion and a proximal end portion, the elongate member defining a longitudinal axis, the distal end portion of the elongate member defining a notch, the notch having a face defining an axis, the axis of the face and the longitudinal axis defining an acute angle with respect to a first direction along the longitudinal axis, the notch configured to retain a loop of the suture when the elongate member is moved through a tissue of a patient in the first direction along the longitudinal axis, the notch configured to release the loop of the suture when the elongate member is moved through the tissue of the patient in a second direction different than the first direction, the suture being coupled to a plurality of tissue anchors configured to be disposed within the tissue of the patient,at least one tissue anchor of the plurality of tissue anchors having a first end portion defining a first point and a second end portion defining a second point, the first end portion being opposite the second end portion, the first end portion and the second end portion defining a longitudinal line, the suture being coupled to the first end portion and the second end portion of the at least one tissue anchor and then extending to a first end portion of an adjacent tissue anchor of the plurality of tissue anchors to be coupled thereto,the at least one tissue anchor having a body portion defining at least one retaining member configured to permit movement through the tissue in the first direction and limit movement through the tissue in the second direction,the at least one tissue anchor defining a first opening and a second opening, the suture being coupled to the at least one tissue anchor at the first end portion by extending through the first opening and looping around the first end portion and at the second end portion by extending from the first end portion through the second opening and looping around the second end portion.
  • 2. The apparatus of claim 1, wherein the loop of the suture remains within the tissue of the patient when the elongate member is moved in the second direction.
  • 3. The apparatus of claim 1, further comprising: an adjustable stop coupled to the elongate member, the adjustable stop having a first configuration and a second configuration, the adjustable stop configured to move with respect to the elongate member when in the first configuration, the adjustable stop configured to maintain its position with respect to the elongate member when in the second configuration, the adjustable stop configured to limit the distance between an outer surface of the tissue and the distal end portion of the elongate member when the adjustable stop is in its second configuration and the elongate member is inserted into the tissue of the patient such that the adjustable stop contacts the outer surface of the tissue.
  • 4. The apparatus of claim 1, wherein the distal end portion of the elongate member includes a tissue piercing portion configured to penetrate the tissue of the patient.
  • 5. The apparatus of claim 1, wherein the elongate member is substantially solid.
  • 6. The apparatus of claim 1, wherein the elongate member is substantially rigid.
  • 7. The apparatus of claim 1, wherein the face of the notch is a first face of the notch, the notch having a second face defining an axis, the axis of the second face and the longitudinal axis defining an obtuse angle with respect to the second direction.
  • 8. The apparatus of claim 1, wherein the second end portion includes a coupling portion, the coupling portion includes an inner wall of the second opening such that when the suture is coupled to the second end portion, the suture engages the inner wall of the second opening of the second end portion.
  • 9. An apparatus, comprising: an elongate member having a distal end portion and a proximal end portion, the distal end portion of the elongate member defining a notch configured to releasably retain a loop of a suture when the elongate member is inserted into a tissue of a patient a distance; andan adjustable stop movably coupled to the elongate member, the adjustable stop configured to allow a user to determine a distance the elongate member is inserted into the tissue, the adjustable stop including a body portion, a first leg portion extending from the body portion, and a second leg portion extending from the body portion, the body portion defining a lumen that extends an entire length of the body portion, the lumen configured to receive the elongate member, the body portion defining a slit that extends from the lumen to an edge of the body portion, the first leg portion and the second leg portion being adjacent to the slit such that end portions of the first leg portion and the second leg portion are configured to move in a direction toward each other to expand the slit disposed between the first leg portion and the second leg portion when viewed from an end of the adjustable stop, the first leg portion and the second leg portion cross each other at approximately mid-portions of the respective first and second leg portions.
  • 10. The apparatus of claim 9, wherein the body portion defines a first face and a second face opposite to the first face, the first face configured to contact an outer portion of the tissue when the elongate member is inserted into the tissue the distance.
  • 11. The apparatus of claim 9, wherein the distance is a first distance, the adjustable stop having a first position with respect to the elongate member and a second position with respect to the elongate member, the elongate member configured to be inserted into the tissue of the patient the first distance when the adjustable stop is in the first position, the elongate member configured to be inserted into the tissue of the patient a second distance when the adjustable stop is in the second position, the second distance being greater than the first distance.
  • 12. The apparatus of claim 9, wherein the elongate member defines a longitudinal axis, the elongate member being configured to be inserted into the tissue of the patient in a direction substantially along the longitudinal axis.
  • 13. The apparatus of claim 9, wherein the notch is configured to retain the loop of the suture when the elongate member is moved in a first direction through the tissue of the patient, the notch being configured to release the loop of the suture when the elongate member is moved in a second direction substantially opposite the first direction.
  • 14. The apparatus of claim 9, wherein the elongate member is substantially solid.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of, and claims priority to, U.S. patent application Ser. No. 12/760,049, filed on Apr. 14, 2010, entitled “APPARATUS FOR DELIVERING AND ANCHORING IMPLANTABLE MEDICAL DEVICES”, which, in turn, claims the benefit of and priority to U.S. Patent Application No. 61/170,312, filed on Apr. 17, 2009, entitled “APPARATUS FOR AND METHOD OF DELIVERING AND ANCHORING IMPLANTABLE MEDICAL DEVICES”, both of which are incorporated by reference herein their entireties.

US Referenced Citations (215)
Number Name Date Kind
527263 Blanchard Oct 1894 A
3182662 Shirodkar May 1965 A
3212502 Myers Oct 1965 A
3311110 Singerman et al. Mar 1967 A
3372695 Beliveau et al. Mar 1968 A
3472232 Earl Oct 1969 A
3565073 Giesy Feb 1971 A
3608095 Barry Sep 1971 A
3704712 Giesy et al. Dec 1972 A
3763860 Clarke Oct 1973 A
3858783 Kapitanov et al. Jan 1975 A
3924633 Cook et al. Dec 1975 A
4037603 Wendroff Jul 1977 A
4128100 Wendroff Dec 1978 A
4221212 Miller Sep 1980 A
4235238 Ogiu et al. Nov 1980 A
4392495 Bayers Jul 1983 A
4441497 Paudler Apr 1984 A
4509516 Richmond Apr 1985 A
4549545 Levy Oct 1985 A
4583540 Malmin Apr 1986 A
4735615 Uddo, Jr. et al. Apr 1988 A
4798193 Geisy et al. Jan 1989 A
4824435 Giesy et al. Apr 1989 A
4872451 Moore et al. Oct 1989 A
4946467 Ohi et al. Aug 1990 A
4946468 Li Aug 1990 A
4976717 Boyle Dec 1990 A
5002550 Li Mar 1991 A
5013292 Lemay May 1991 A
5032508 Naughton et al. Jul 1991 A
5064435 Porter Nov 1991 A
5078730 Li et al. Jan 1992 A
5080667 Chen et al. Jan 1992 A
5084058 Li Jan 1992 A
5085661 Moss Feb 1992 A
5087263 Li Feb 1992 A
5112344 Petros May 1992 A
5149329 Richardson Sep 1992 A
5152749 Giesy et al. Oct 1992 A
5180385 Sontag Jan 1993 A
5207679 Li May 1993 A
5217438 Richard et al. Jun 1993 A
5250033 Evans et al. Oct 1993 A
5256150 Quiachon et al. Oct 1993 A
5281237 Gimpelson Jan 1994 A
5292327 Dodd et al. Mar 1994 A
5312422 Trott May 1994 A
5334185 Giesy et al. Aug 1994 A
5337736 Reddy Aug 1994 A
5362294 Seitzinger Nov 1994 A
5368595 Lewis Nov 1994 A
5368756 Vogel et al. Nov 1994 A
5382257 Lewis et al. Jan 1995 A
5383904 Totakura et al. Jan 1995 A
5395349 Quiachon et al. Mar 1995 A
5403328 Shallman Apr 1995 A
5439467 Benderev et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5450860 O'Connor Sep 1995 A
5456722 McLeod et al. Oct 1995 A
5499991 Garman et al. Mar 1996 A
5505735 Li Apr 1996 A
5507796 Hasson Apr 1996 A
5520700 Beyar et al. May 1996 A
5527342 Pietrzak et al. Jun 1996 A
5540703 Barker et al. Jun 1996 A
5571119 Atala Nov 1996 A
5582188 Benderev et al. Dec 1996 A
5611515 Benderev et al. Mar 1997 A
5628756 Barker et al. May 1997 A
5645568 Chervitz et al. Jul 1997 A
5645589 Li Jul 1997 A
5683418 Luscombe et al. Nov 1997 A
5690649 Li Nov 1997 A
5702215 Li Dec 1997 A
5741299 Rudt Apr 1998 A
5742943 Chen Apr 1998 A
5749884 Benderev et al. May 1998 A
5816258 Jervis Oct 1998 A
5836315 Benderev et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5855549 Newman Jan 1999 A
5860425 Benderev et al. Jan 1999 A
5860993 Thompson et al. Jan 1999 A
5891168 Thal Apr 1999 A
5899906 Schenk May 1999 A
5899909 Claren et al. May 1999 A
5899999 De Bonet May 1999 A
5931855 Buncke Aug 1999 A
5934283 Willem et al. Aug 1999 A
5935122 Fourkas et al. Aug 1999 A
5945122 Abra et al. Aug 1999 A
5954057 Li Sep 1999 A
5984933 Yoon Nov 1999 A
5997554 Thompson Dec 1999 A
6010447 Kardjian Jan 2000 A
6030393 Corlew Feb 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6050937 Benderev Apr 2000 A
6053935 Brenneman et al. Apr 2000 A
6096041 Gellman et al. Aug 2000 A
6099547 Gellman et al. Aug 2000 A
6110101 Tihon et al. Aug 2000 A
6117067 Gil-Vernet Sep 2000 A
6200330 Benderev Mar 2001 B1
6221005 Bruckner et al. Apr 2001 B1
6221084 Fleenor Apr 2001 B1
6264676 Gellman et al. Jul 2001 B1
6273852 Lehe et al. Aug 2001 B1
6306079 Trabucco Oct 2001 B1
6306156 Clark Oct 2001 B1
6334446 Beyar Jan 2002 B1
6382214 Raz et al. May 2002 B1
6398787 Itoman Jun 2002 B1
6406423 Scetbon Jun 2002 B1
6423072 Zappala Jul 2002 B1
6423080 Gellman et al. Jul 2002 B1
6475139 Miller Nov 2002 B1
6478727 Scetbon Nov 2002 B2
6491703 Ulmsten Dec 2002 B1
6494887 Kaladelfos Dec 2002 B1
6530943 Hoepffner et al. Mar 2003 B1
6582443 Cabak et al. Jun 2003 B2
6596001 Stormby et al. Jul 2003 B2
6596002 Therin et al. Jul 2003 B2
6599235 Kovac Jul 2003 B2
6605097 Lehe et al. Aug 2003 B1
6612977 Staskin et al. Sep 2003 B2
6635058 Beyar Oct 2003 B2
6638209 Landgrebe Oct 2003 B2
6638210 Berger Oct 2003 B2
6638211 Suslian et al. Oct 2003 B2
6641525 Rocheleau et al. Nov 2003 B2
6648921 Anderson et al. Nov 2003 B2
6652450 Neisz et al. Nov 2003 B2
6652561 Tran Nov 2003 B1
6685629 Therin Feb 2004 B2
6691711 Raz et al. Feb 2004 B2
6730110 Harari et al. May 2004 B1
6755781 Gellman Jun 2004 B2
6802807 Anderson et al. Oct 2004 B2
6830052 Carter et al. Dec 2004 B2
6848152 Genova Feb 2005 B2
6932759 Kammerer et al. Aug 2005 B2
7377926 Topper et al. May 2008 B2
7381212 Topper et al. Jun 2008 B2
7387634 Benderev Jun 2008 B2
7524281 Chu et al. Apr 2009 B2
8449573 Chu May 2013 B2
8591545 Lunn et al. Nov 2013 B2
8968334 Ostrovsky Mar 2015 B2
9011489 Ostrovsky et al. Apr 2015 B2
9289204 Chu Mar 2016 B2
20010018549 Scetbon Aug 2001 A1
20010037119 Schmieding Nov 2001 A1
20010049467 Lehe et al. Dec 2001 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020058959 Gellman May 2002 A1
20020072694 Snitkin et al. Jun 2002 A1
20020077526 Kammerer et al. Jun 2002 A1
20020091373 Berger Jul 2002 A1
20020116025 Haab Aug 2002 A1
20020128670 Ulmsten et al. Sep 2002 A1
20020138025 Gellman et al. Sep 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151910 Gellman et al. Oct 2002 A1
20020161382 Neisz et al. Oct 2002 A1
20020188169 Kammerer et al. Dec 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20030004395 Therin Jan 2003 A1
20030004580 Sump et al. Jan 2003 A1
20030009181 Gellman et al. Jan 2003 A1
20030010929 Priewe et al. Jan 2003 A1
20030023135 Ulmsten et al. Jan 2003 A1
20030023138 Luscombe Jan 2003 A1
20030028075 Ulmsten et al. Feb 2003 A1
20030050530 Neisz et al. Mar 2003 A1
20030065336 Xiao Apr 2003 A1
20030088272 Smith May 2003 A1
20030100954 Schuldt-Hempe et al. May 2003 A1
20030120309 Colleran Jun 2003 A1
20030130670 Anderson et al. Jul 2003 A1
20030149440 Kammerer et al. Aug 2003 A1
20030171644 Anderson et al. Sep 2003 A1
20030171778 Lizardi Sep 2003 A1
20030176762 Kammerer Sep 2003 A1
20030195386 Thierfelder et al. Oct 2003 A1
20030220538 Jacquetin Nov 2003 A1
20040002734 Fallin Jan 2004 A1
20040039453 Anderson et al. Feb 2004 A1
20040087978 Velez et al. May 2004 A1
20040098053 Tran May 2004 A1
20040106847 Benderev Jun 2004 A1
20040237736 Genova et al. Dec 2004 A1
20050203576 Sulamanidze et al. Sep 2005 A1
20050228406 Bose Oct 2005 A1
20060173491 Meade et al. Aug 2006 A1
20060217589 Wan et al. Sep 2006 A1
20060229596 Weiser et al. Oct 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070016135 Kanner Jan 2007 A1
20070038249 Kolster Feb 2007 A1
20070112384 Conlon May 2007 A1
20070129758 Saadat Jun 2007 A1
20080103527 Martin et al. May 2008 A1
20080132931 Mueller Jun 2008 A1
20090076529 Ganti Mar 2009 A1
20090287245 Ostrovsky et al. Nov 2009 A1
20100268255 Ostrovsky et al. Oct 2010 A1
20100324357 Chu Dec 2010 A1
20110106108 Ostrovsky et al. May 2011 A1
20130253259 Chu Sep 2013 A1
20160193025 Chu Jul 2016 A1
Foreign Referenced Citations (42)
Number Date Country
3223153 Aug 1983 DE
4220283 Dec 1993 DE
4334419 Apr 1995 DE
10103179 Jul 2001 DE
2007015955 Apr 2009 DE
0598976 Jun 1994 EP
0599772 Jun 1994 EP
0688056 Dec 1995 EP
0774240 May 1997 EP
0941712 Sep 1999 EP
1025811 Aug 2000 EP
2422386 Nov 1979 FR
2005-532848 Nov 2005 JP
2006-515204 May 2006 JP
2007-532174 Nov 2007 JP
2007-535335 Dec 2007 JP
1225547 Apr 1986 RU
1443873 Dec 1988 RU
503271 Apr 1996 SE
1990003766 Apr 1990 WO
1996006567 Mar 1996 WO
1996006597 Mar 1996 WO
1997013465 Apr 1997 WO
1998031301 Jul 1998 WO
1998034545 Aug 1998 WO
2000074594 Dec 2000 WO
2001006951 Feb 2001 WO
2001078609 Oct 2001 WO
2002026108 Apr 2002 WO
2002028312 Apr 2002 WO
2002038079 May 2002 WO
2004012626 Feb 2004 WO
2004112585 Dec 2004 WO
2005122954 Dec 2005 WO
2006108145 Oct 2006 WO
2007098212 Aug 2007 WO
2008020937 Feb 2008 WO
2008087635 Jul 2008 WO
2009140012 Nov 2009 WO
2010065274 Jun 2010 WO
2010121052 Oct 2010 WO
2010121052 Jan 2011 WO
Non-Patent Literature Citations (83)
Entry
International Search Report and Written Opinion for PCT Application No. PCT/US2009/040587, dated Oct. 21, 2009, 13 pages.
International Search Report and written Opinion for PCT Application No. PCT/US2009/064564, dated Feb. 23, 2010, 13 pages.
International Preliminary Report on Patentability for PCT Patent Application No. PCT/US2009/040587, dated Nov. 25, 2010, 10 pages.
International Search Report and Written opinion for PCT Patent Application No. PCT/US2010/031273, dated Dec. 1, 2010, 17 Pages.
International Preliminary Report on Patentability for PCT Application No. PCT/US2009/064564, dated Jun. 16, 2011, 9 pages.
Restriction Requirement for U.S. Appl. No. 12/760,049, dated Mar. 29, 2012, 9 pages.
Response to Restriction Requirement for U.S. Appl. No. 12/760,049, filed Apr. 27, 2012, 2 pages.
Non-Final Office Action for U.S. Appl. No. 12/760,049, dated Jun. 1, 2012, 10 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/760,049, filed Aug. 29, 2012, 8 pages.
Final Office Action for U.S. Appl. No. 12/760,049, dated Nov. 8, 2012, 17 pages.
Response to Final Office Action for U.S. Appl. No. 12/760,049, filed Feb. 8, 2013, 8 pages.
Non-Final Office Action for U.S. Appl. No. 12/760,049, dated Oct. 3, 2013, 18 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/760,049, filed Dec. 23, 2013, 10 pages.
Final Office Action for U.S. Appl. No. 12/760,049, dated Apr. 4, 2014, 37 pages.
Response to Final Office Action for U.S. Appl. No. 12/760,049, filed May 28, 2014, 9 pages.
Non-Final Office Action for U.S. Appl. No. 12/760,049, dated Jun. 19, 2014, 22 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/760,049, filed Sep. 17, 2014, 9 pages.
Notice of Allowance for U.S. Appl. No. 12/760,049, dated Oct. 24, 2014, 7 pages.
Restriction Requirement for U.S. Appl. No. 12/394,965, dated May 18, 2011, 6 pages.
Restriction Requirement Response for U.S. Appl. No. 12/394,965, filed Jun. 15, 2011, 1 page.
Non-Final Office Action for U.S. Appl. No. 12/394,965, dated Aug. 8, 2011, 8 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/394,965, filed Nov. 3, 2011, 10 pages.
Non-Final Office Action for U.S. Appl. No. 12/394,965, dated Mar. 2, 2012, 13 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/394,965, filed Jun. 4, 2012, 09 pages.
Final Office Action for U.S. Appl. No. 12/394,965, dated Dec. 7, 2012, 15 pages.
Response to Final Office Action for U.S. Appl. No. 12/394,965, filed Mar. 5, 2013, 9 pages.
Non-Final Office Action for U.S. Appl. No. 12/394,965, dated Mar. 21, 2013, 14 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/394,965, filed Jul. 17, 2013, 10 pages.
Final Office Action for U.S. Appl. No. 12/394,965, dated Oct. 31, 2013, 13 pages.
Response to Final Office Action for U.S. Appl. No. 12/394,965, filed Jan. 31, 2014, 11 pages.
Notice of Allowance for U.S. Appl. No. 12/394,965, dated Dec. 17, 2014, 8 pages.
Non-Final Office Action for U.S. Appl. No. 12/549,704, dated Sep. 26, 2011, 9 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/549,704, filed Dec. 23, 2011, 7 pages.
Final Office Action for U.S. Appl. No. 12/549,704, dated Jan. 30, 2012, 10 pages.
Response to Final Office Action for U.S. Appl. No. 12/549,704, filed Apr. 27, 2012, 8 pages.
Non-Final Office Action for U.S. Appl. No. 12/549,704, dated Jul. 25, 2012, 10 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/549,704, filed Oct. 25, 2012, 8 pages.
Final Office Action for U.S. Appl. No. 12/549,704, dated Nov. 20, 2012, 12 pages.
Response to Final Office Action for U.S. Appl. No. 12/549,704, filed Jan. 18, 2013, 8 pages.
Notice of Allowance for U.S. Appl. No. 12/549,704, dated Feb. 1, 2013, 9 pages.
Restriction Requirement for U.S. Appl. No. 12/938,553, dated Dec. 28, 2012, 9 pages.
Response to Restriction Requirement for U.S. Appl. No. 12/938,553, filed Jan. 25, 2013, 2 pages.
Non-Final Office Action for U.S. Appl. No. 12/938,553, dated Jun. 7, 2013, 7 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/938,553, filed Sep. 3, 2013, 8 pages.
Non-Final Office Action for U.S. Appl. No. 12/938,553, dated Dec. 19, 2013, 8 pages.
Response to Non-Final Office Action for U.S. Appl. No. 12/938,553, filed Mar. 17, 2014, 8 pages.
Final Office Action for U.S. Appl. No. 12/938,553, dated Aug. 6, 2014, 8 pages.
Response to Final Office Action for U.S. Appl. No. 12/938,553, filed Sep. 30, 2014, 7 pages.
Advisory Action for U.S. Appl. No. 12/938,553, dated Oct. 21, 2014, 2 pages.
Office Action for Japanese Patent Application No. 2011-509522, dated May 22, 2013, 4 pages. (Official Communication Only).
Office Action for Japanese Patent Application No. 2011-509522, dated Sep. 13, 2013, 2 pages. (Official Communication Only).
Office Action for Japanese Patent Application No. 2011-509522, dated Jun. 12, 2014, 7 pages. (3 Pages Office Action + 4 Pages English translation).
First Examiner Report for Australian Patent Application No. 2009322835, dated May 21, 2014, 3 pages.
Bayer et al., “A New Approach to Primary Strengthening of Colostomy With Marlex Mesh to Prevent Paracolostomy Hernia”, Surg Gynecol Obstet, vol. 163, No. 6 ,Dec. 1986 ,1 page. (Abstract Only).
Delorme, Emmanuel, “La Bandelette Trans-Obturatrice: Un Procede Mini-Invasif Pour Traiter L'incontinence Urinaire D'effort De La Femme”, Progres en Urologie with English translated Abstract ,2001 ,pp. 1306-1313 and 1 page of translation.
Fianu et al., “Absorbable Polyglactin Mesh for Retropubic Sling Operation in Female Urinary Stress Incontinence”, Gynecol. Obstet. Invest., vol. 16, 1983, pp. 45-50 , 1983 , 1 page.
Giberti, C. , “TVT Tension-free Vaginal Tape, Minimally Invasive Highly Effective Treatment for Female Stress Unrinary Incontinence”, Urology vol. 57 No. 4 ,2001 ,pp. 666-669.
Gittes et al., “No-Incision Pubovaginal Suspension for Stress Incontinence”, Journal of Urology, vol. 138 No. 3 , Sep. 1987 , pp. 568-570.(Abstract Only).
Haab et al., “Feasibility of Outpatient Percutaneous Bladder Neck Suspension Under Local Anesthesia”, Urology vol. 50 No. 4 ,Oct. 1997 ,pp. 585-587.(Abstract Only).
Kovac et al., “Pubic Bone Suburethral Stabilization Sling for Recurrent Urinary Incontinence”, Obstetrics & Gynecology, vol. 89, No. 4, Apr. 1997, pp. 624-627.(Abstract Only).
Norris et al., “Use of Synthetic Material in Sling Surgery: A Minimally Invasive Approach”, Journal of Endourology, vol. 10, Issue 3 ,Jun. 1996 ,pp. 227-230.(Abstract Only).
Petros et al., “An Integral Theory and Its Method for the Diagnosis and Management of Female Urinary Incontinence”, Scandinavian Journal of Urology and Nephrology, An Integral Theory and its Method for the Diagnosis ,1993, pp. 1-93.
Petros, P., “An Integral Theory of Bladder Neck Opening, Closure and Urinary incontinence in the Female”, International Journal of Gynecology & Obstetrics. XXIII World Congress of Gynaecology and Obstetrics (FIGO) ,1991.
Petro, P. P., “Medium-term Follow-up of the Intravaginal Slingplasty Operation Indicates Minimal Deterioration of Urinary Continence with Time”, Aust NZ J Obstet Gynaecol vol. 39 No. 3 ,Aug. 1999,pp. 354-356.
Petros, P., “The Intravaginal Slingplasty Operation, a Minimally Invasive Technique for Cure of Urinary Incontinence in the Female”, Aust. NZ J Obstet Gynaecol, vol. 36, No. 4 ,1996, pp. 453-461. (Abstract Only).
Petros et al., “Urethral Pressure Increase on Effort Originates from Within the Urethra, and Continence From Musculovaginal Closure”, Neurourology and Urodynamics vol. 14 No. 4 ,1995 ,pp. 337-346.
Petros, P E., “Vault Prolapse I: Dynamic Supports of the Vagina”, Int Urogynecol J Pelvic Floor Dysfunct vol. 12 No. 5 ,2001 ,pp. 292-295.
Raz et al., “Fascial Sling to Correct Male Neurogenic Sphincter Incompetence: The McGuire/RAZ Approach”, Journal of Urology vol. 139 No. 3 ,Mar. 1988 ,pp. 528-531.
Raz, S., “Modified Bladder Neck Suspension for Female Stress Incontinence”, Urology vol. 17 No. 1 ,Jan. 1981 , pp. 82-85.
Raz et al., “Vaginal Wall Sling”, The Journal of Urology vol. 141, 1989, pp. 43-46.
Richardson, P A., “Ambulatory Surgery for Urinary Incontinence and Vaginal Prolapse”, Medical Journal of Australia vol. 161 No. 8,1994, pp. 171-172.
Stamey, Thomas A., “Endoscopic Suspension of the Vesical Neck for Urinary Incontinence in Females”, Annals of Surgery vol. 192 No. 4 ,Oct. 1980 ,pp. 465-471.
Starney, T. A., “Endoscopic Suspension of the Vesical Neck for Urinary Incontinence Surgery”, Gynecology & Obstetrics vol. 136 No. 4 ,1973 ,pp. 547-554.
Staskin, D. R., “Sling Surgery for the Treatment of Female”, Stress Incontinence vol. 5 No. 1 ,1991 ,pp. 106-122.
Staskin et al., “The Gore-Tex Sling Procedure for Female Sphincteric Incontinence: Indications, Technique, and Results”, World J of Urol. vol. 15 No. 5 ,1997, pp. 295-299.
Ulmsten, U., “An Ambulatory Surgical Procedure Under Local Anesthesia for Treatment of Female Urinary Incontinence”, The International Urogynecology Journal vol. 7 No. 2 ,1996 ,pp. 81-86.
Ulmsten, U., “An Introduction to Tension-Free Vaginal Tape (TVT)—A New Surgical Procedure for Treatment of Female Urinary Incontinence”, Int Urogynecol J. Pelvic Floor Dysfunct. (Suppl 2) ,2001,pp. S3-S4.
Ulmsten, U., “Connective Tissue Factors in the Aetiology of Female Pelvic Disorders”, Ann. Med vol. 22 No. 6 , Dec. 1990 ,pp. 403.
Ulmsten et al., “Intravaginal Slingplasty”, Zentralbl Gynakol vol. 116 ,1994 ,pp. 398-404.
Ulmsten et al., “Intravaginal Slingplasty (IVS): An Ambulatory Surgical Procedure for Treatment of Female Urinary Incontinence”, Scand J Urol Nephrol vol. 29 No. 1 ,Mar. 1995 ,pp. 75-82.
Ulmsten et al., “Surgery for Female Urinary Incontinence”, Current Opinion in Obstetrics & Gynecology vol. 4 No. 3 ,1992 ,pp. 456-462.
Ulmsten, U., “The Basic Understanding and Clinical Results of Tension-Free Vaginal Tape for Stress Urinary Incontinence”, Urologe A., Jul. 2001 ,pp. 269-273.
freedictionary.com, “Suture”, available online at <http://www.thefreedictionary.com/suture>, Retrieved on May 21, 2012, 3 pages.
Related Publications (1)
Number Date Country
20150148820 A1 May 2015 US
Provisional Applications (1)
Number Date Country
61170312 Apr 2009 US
Continuations (1)
Number Date Country
Parent 12760049 Apr 2010 US
Child 14610861 US